Lyell Immunopharma

Lyell Immunopharma

A biotechnology company developing cellular immunotherapies for treating cancer.

Would it be accurate and relevant to link the text highlighted below to the topic Altitude Life Science VenturesAltitude Life Science Ventures?

On February 8, 2019 Lyell Immunopharma completed their series B funding round with $179 million in funding from 8VC, Altitude Life Science Ventures, ARCH Venture Partners, Forsite Capital Management, and BMGI. 

This text snippet is from the topic Lyell ImmunopharmaLyell Immunopharma